연속 혈당 모니터링 시스템 시장 : 산업 분석, 시장 규모, 점유율, 성장, 동향, 예측(2025-2032년)

Persistence Market Research has recently released a comprehensive report on the global Continuous Glucose Monitoring (CGM) Systems Market. The report offers an in-depth assessment of key market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global CGM systems market from 2025 to 2032.

Key Insights:

• Continuous Glucose Monitoring Systems Market Size (2025E): USD 11.97 Billion
• Projected Market Value (2032F): USD 22.76 Billion
• Global Market Growth Rate (CAGR 2025 to 2032): 9.6%

Continuous Glucose Monitoring Systems Market - Report Scope:

Continuous Glucose Monitoring (CGM) systems play a pivotal role in managing diabetes, providing real-time data on glucose levels for better control and prevention of diabetes-related complications. The market caters to hospitals, clinics, homecare settings, and diabetes management centers, offering a range of CGM devices, including wearable sensors, transmitters, and receivers. CGM systems allow for continuous monitoring of glucose levels, eliminating the need for traditional finger-prick tests. The market growth is driven by the rising prevalence of diabetes, technological advancements in CGM devices, and the increasing demand for non-invasive glucose monitoring solutions.

Market Growth Drivers:

Several key factors drive the global CGM systems market, including the rising global incidence of diabetes, particularly Type 1 and Type 2, which fuels the demand for effective glucose monitoring solutions. Technological advancements, such as the development of more accurate, user-friendly, and affordable CGM devices, enhance the effectiveness and accessibility of these systems, promoting their widespread adoption. Furthermore, the increasing focus on personalized medicine and data-driven healthcare solutions has accelerated the integration of CGM technology into both clinical and homecare settings. The growing awareness of the benefits of continuous glucose monitoring for better diabetes management also supports market growth.

Market Restraints:

Despite the promising growth prospects, the CGM systems market faces challenges, including high costs associated with CGM devices and sensors, which can limit accessibility, especially in emerging economies. Additionally, regulatory hurdles, reimbursement issues, and concerns over device accuracy and reliability may pose barriers to widespread adoption. While CGM systems offer significant benefits in terms of glucose control, the complexity of some devices and the need for regular calibration can also limit their appeal for certain patient groups.

Market Opportunities:

The CGM systems market presents substantial opportunities driven by technological advancements, growing demand for diabetes management tools, and the rising shift towards home-based healthcare. Innovations such as smartphone connectivity, real-time data sharing, and AI-driven insights are enhancing the functionality and user experience of CGM devices. The expansion of CGM technology into other therapeutic areas, such as obesity management and pre-diabetes monitoring, further broadens the market's scope. Moreover, strategic partnerships between CGM device manufacturers, healthcare providers, and insurers can help address cost concerns and improve access to these life-saving technologies.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the CGM systems market globally?
• Which CGM devices and technologies are gaining traction across different healthcare settings?
• How are technological advancements shaping the competitive landscape of the CGM systems market?
• Who are the key players contributing to the CGM systems market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global CGM systems market?

Competitive Intelligence and Business Strategy:

Leading players in the global CGM systems market, such as Abbott Laboratories, Dexcom, Inc., and Medtronic, are focusing on innovation, product differentiation, and strategic partnerships to maintain a competitive edge. These companies invest heavily in research and development to create more accurate, cost-effective, and user-friendly CGM solutions. Collaborations with healthcare providers, insurance companies, and regulatory bodies aim to increase patient access to CGM devices and improve adoption rates. Clinical studies and real-world data also play a significant role in fostering market growth and promoting the adoption of CGM systems.

Key Companies Profiled:

• Abbott Laboratories
• Dexcom, Inc.
• Medtronic
• Roche Diagnostics
• Senseonics Holdings, Inc.
• GlySens Incorporated
• Ascensia Diabetes Care
• Insulet Corporation
• Tandem Diabetes Care, Inc.

Continuous Glucose Monitoring Systems Market Research Segmentation

By Component:

• Transmitters and Monitors
• Sensors
• Insulin Pump

By End User:

• Home Care Diagnostics
• Hospitals
• ICU/Critical Care

By Region:

• North America
• Europe
• East Asia
• South Asia & Oceania
• Latin America
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Continuous Glucose Monitoring Systems Market Snapshot, 2025 - 2032
• 1.2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. Industry Developments and Key Market Events
• 1.7. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Challenges
  • 2.2.5. Key Trends
• 2.3. Component Lifecycle Analysis
• 2.4. Continuous Glucose Monitoring Systems Market: Value Chain
  • 2.4.1. List of Raw Material Supplier
  • 2.4.2. List of Manufacturers
  • 2.4.3. List of Distributors
  • 2.4.4. List of Vehicle Types
  • 2.4.5. Profitability Analysis
• 2.5. Porter Five Force's Analysis
• 2.6. Geopolitical Tensions: Market Impact
• 2.7. Macro-Economic Factors
  • 2.7.1. Global Sectorial Outlook
  • 2.7.2. Global GDP Growth Outlook
  • 2.7.3. Global Parent Market Overview
• 2.8. Forecast Factors - Relevance and Impact
• 2.9. Regulatory and Technology Landscape

3. Global Continuous Glucose Monitoring Systems Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 3.1. Key Highlights
  • 3.1.1. Market Volume (Units) Projections
  • 3.1.2. Market Size and Y-o-Y Growth
  • 3.1.3. Absolute $ Opportunity
• 3.2. Market Size (US$ Mn) Analysis and Forecast
  • 3.2.1. Historical Market Size Analysis, 2019 - 2023
  • 3.2.2. Current Market Size Forecast, 2025 - 2032
• 3.3. Global Continuous Glucose Monitoring Systems Market Outlook: Component
  • 3.3.1. Introduction / Key Findings
  • 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Component, 2019 - 2023
  • 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Component, 2025 - 2032
    • 3.3.3.1. Transmitters and Monitors
    • 3.3.3.2. Sensors
    • 3.3.3.3. Insulin Pump
• 3.4. Market Attractiveness Analysis: Component
• 3.5. Global Continuous Glucose Monitoring Systems Market Outlook: End User
  • 3.5.1. Introduction / Key Findings
  • 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2019 - 2023
  • 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
    • 3.5.3.1. Home Care Diagnostics
    • 3.5.3.2. Hospitals
    • 3.5.3.3. ICU/Critical Care
• 3.6. Market Attractiveness Analysis: End User

4. Global Continuous Glucose Monitoring Systems Market Outlook: Region

• 4.1. Key Highlights
• 4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2019 - 2023
• 4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2025 - 2032
  • 4.3.1. North America
  • 4.3.2. Europe
  • 4.3.3. East Asia
  • 4.3.4. South Asia and Oceania
  • 4.3.5. Latin America
  • 4.3.6. Middle East & Africa (MEA)
• 4.4. Market Attractiveness Analysis: Region

5. North America Continuous Glucose Monitoring Systems Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 5.1. Key Highlights
• 5.2. Pricing Analysis
• 5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
  • 5.3.1. By Country
  • 5.3.2. By Component
  • 5.3.3. By End User
• 5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
  • 5.4.1. U.S.
  • 5.4.2. Canada
• 5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Component, 2025 - 2032
  • 5.5.1. Transmitters and Monitors
  • 5.5.2. Sensors
  • 5.5.3. Insulin Pump
• 5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
  • 5.6.1. Home Care Diagnostics
  • 5.6.2. Hospitals
  • 5.6.3. ICU/Critical Care
• 5.7. Market Attractiveness Analysis

6. Europe Continuous Glucose Monitoring Systems Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 6.1. Key Highlights
• 6.2. Pricing Analysis
• 6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
  • 6.3.1. By Country
  • 6.3.2. By Component
  • 6.3.3. By End User
• 6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
  • 6.4.1. Germany
  • 6.4.2. France
  • 6.4.3. U.K.
  • 6.4.4. Italy
  • 6.4.5. Spain
  • 6.4.6. Russia
  • 6.4.7. Turkey
  • 6.4.8. Rest of Europe
• 6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Component, 2025 - 2032
  • 6.5.1. Transmitters and Monitors
  • 6.5.2. Sensors
  • 6.5.3. Insulin Pump
• 6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
  • 6.6.1. Home Care Diagnostics
  • 6.6.2. Hospitals
  • 6.6.3. ICU/Critical Care
• 6.7. Market Attractiveness Analysis

7. East Asia Continuous Glucose Monitoring Systems Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 7.1. Key Highlights
• 7.2. Pricing Analysis
• 7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
  • 7.3.1. By Country
  • 7.3.2. By Component
  • 7.3.3. By End User
• 7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
  • 7.4.1. China
  • 7.4.2. Japan
  • 7.4.3. South Korea
• 7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Component, 2025 - 2032
  • 7.5.1. Transmitters and Monitors
  • 7.5.2. Sensors
  • 7.5.3. Insulin Pump
• 7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
  • 7.6.1. Home Care Diagnostics
  • 7.6.2. Hospitals
  • 7.6.3. ICU/Critical Care
• 7.7. Market Attractiveness Analysis

8. South Asia & Oceania Continuous Glucose Monitoring Systems Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 8.1. Key Highlights
• 8.2. Pricing Analysis
• 8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
  • 8.3.1. By Country
  • 8.3.2. By Component
  • 8.3.3. By End User
• 8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
  • 8.4.1. India
  • 8.4.2. Southeast Asia
  • 8.4.3. ANZ
  • 8.4.4. Rest of South Asia & Oceania
• 8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Component, 2025 - 2032
  • 8.5.1. Transmitters and Monitors
  • 8.5.2. Sensors
  • 8.5.3. Insulin Pump
• 8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
  • 8.6.1. Home Care Diagnostics
  • 8.6.2. Hospitals
  • 8.6.3. ICU/Critical Care
• 8.7. Market Attractiveness Analysis

9. Latin America Continuous Glucose Monitoring Systems Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 9.1. Key Highlights
• 9.2. Pricing Analysis
• 9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
  • 9.3.1. By Country
  • 9.3.2. By Component
  • 9.3.3. By End User
• 9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
  • 9.4.1. Brazil
  • 9.4.2. Mexico
  • 9.4.3. Rest of Latin America
• 9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Component, 2025 - 2032
  • 9.5.1. Transmitters and Monitors
  • 9.5.2. Sensors
  • 9.5.3. Insulin Pump
• 9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
  • 9.6.1. Home Care Diagnostics
  • 9.6.2. Hospitals
  • 9.6.3. ICU/Critical Care
• 9.7. Market Attractiveness Analysis

10. Middle East & Africa Continuous Glucose Monitoring Systems Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 10.1. Key Highlights
• 10.2. Pricing Analysis
• 10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
  • 10.3.1. By Country
  • 10.3.2. By Component
  • 10.3.3. By End User
• 10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
  • 10.4.1. GCC
  • 10.4.2. Egypt
  • 10.4.3. South Africa
  • 10.4.4. Northern Africa
  • 10.4.5. Rest of Middle East & Africa
• 10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Component, 2025 - 2032
  • 10.5.1. Transmitters and Monitors
  • 10.5.2. Sensors
  • 10.5.3. Insulin Pump
• 10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
  • 10.6.1. Home Care Diagnostics
  • 10.6.2. Hospitals
  • 10.6.3. ICU/Critical Care
• 10.7. Market Attractiveness Analysis

11. Competition Landscape

• 11.1. Market Share Analysis, 2024
• 11.2. Market Structure
  • 11.2.1. Competition Intensity Mapping By Market
  • 11.2.2. Competition Analog IC
  • 11.2.3. Apparent Product Capacity
• 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 11.3.1. Herbalife Nutrition
    • 11.3.1.1. Overview
    • 11.3.1.2. Segments and Product
    • 11.3.1.3. Key Financials
    • 11.3.1.4. Market Developments
    • 11.3.1.5. Market Strategy
  • 11.3.2. GNC Holdings
    • 11.3.2.1. Overview
    • 11.3.2.2. Segments and Product
    • 11.3.2.3. Key Financials
    • 11.3.2.4. Market Developments
    • 11.3.2.5. Market Strategy
  • 11.3.3. NOW Health
    • 11.3.3.1. Overview
    • 11.3.3.2. Segments and Product
    • 11.3.3.3. Key Financials
    • 11.3.3.4. Market Developments
    • 11.3.3.5. Market Strategy
  • 11.3.4. Nutramax Laboratories
    • 11.3.4.1. Overview
    • 11.3.4.2. Segments and Product
    • 11.3.4.3. Key Financials
    • 11.3.4.4. Market Developments
    • 11.3.4.5. Market Strategy
  • 11.3.5. Nature's Bounty
    • 11.3.5.1. Overview
    • 11.3.5.2. Segments and Product
    • 11.3.5.3. Key Financials
    • 11.3.5.4. Market Developments
    • 11.3.5.5. Market Strategy
  • 11.3.6. Banyan Botanicals
    • 11.3.6.1. Overview
    • 11.3.6.2. Segments and Product
    • 11.3.6.3. Key Financials
    • 11.3.6.4. Market Developments
    • 11.3.6.5. Market Strategy
  • 11.3.7. Source Naturals
    • 11.3.7.1. Overview
    • 11.3.7.2. Segments and Product
    • 11.3.7.3. Key Financials
    • 11.3.7.4. Market Developments
    • 11.3.7.5. Market Strategy
  • 11.3.8. Nutramarks Inc
    • 11.3.8.1. Overview
    • 11.3.8.2. Segments and Product
    • 11.3.8.3. Key Financials
    • 11.3.8.4. Market Developments
    • 11.3.8.5. Market Strategy
  • 11.3.9. Nature's Way Products
    • 11.3.9.1. Overview
    • 11.3.9.2. Segments and Product
    • 11.3.9.3. Key Financials
    • 11.3.9.4. Market Developments
    • 11.3.9.5. Market Strategy
  • 11.3.10. Abbott
    • 11.3.10.1. Overview
    • 11.3.10.2. Segments and Product
    • 11.3.10.3. Key Financials
    • 11.3.10.4. Market Developments
    • 11.3.10.5. Market Strategy
  • 11.3.11. Natural Immunogenics
    • 11.3.11.1. Overview
    • 11.3.11.2. Segments and Product
    • 11.3.11.3. Key Financials
    • 11.3.11.4. Market Developments
    • 11.3.11.5. Market Strategy

12. Appendix

• 12.1. Research Methodology
• 12.2. Research Assumptions
• 12.3. Acronyms and Abbreviations